Clinical Trial Update: Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating interleukin-6 receptor inhibitor with endovascular treatment for acute ischemic stroke shows efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Interleukin-6 receptor inhibitor

Snippet

Sponsor: Capital Medical University | Conditions: Acute Ischemic Stroke | Phase 3 | Status: ACTIVE_NOT_RECRUITING